Aptagen, LLC
RNA
Dopamine
Small Organic
N/A nM (reported value)
Column Buffer: 50 mM Tris-HCl (pH 7.4), 5 mM MgCl2, and 0.5 M or 0.15 M NaCl
RT°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Dopamine (dopa1.30/c.30) (ID# 402)
5'rGprUprCp rUprCprUp rGprUprGp rUprGprCp rGprCprCp rAprGprAp rGprAprAp rCprAprCp rUprGprGp rGprGprCp rAprGprAp rUprAprUp rGprGprGp rCprCprAp rGprCprAp rCprAprGp rAprAprUp rGp rAprGprGp rCprCprCp3'
65
18784.41 g/mole
567600 L/(mole·cm)
60.34%
1.76
33.09
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Mannironi, C., et al. "In Vitro Selection of Dopamine RNA Ligands." Biochemistry, 36 (1997): 9726-9734.
Have your aptamer oligo synthesized ORDER NOW
We are always looking for ways to improve. Please tell us what you think.